Skip to content
Dr Lalchandani Labs logo

Dr Lalchandani Labs

541299 BSE
₹6.66

Close ·

View as Markdown
MCP
Close 4 Nov 2026 ₹6.66 −9.08 −57.7% 1Y
Start ₹15.74

Key Fundamentals

SMEHealthcare ServicesHealthcare

Price-based figures at the close · TTM

ROCE
0.79%
Debt to Equity
0.15
EPS (TTM)
—
Book Value
₹16.37
Market Cap
—
P/E (TTM)
—
P/B
0.41
ROE
0.50%
Dividend Yield
0.00%
EBITDA
₹69.00 L
52W High
₹17.99
52W Low
₹5.81

Key Insights

Strengths

2
  • Company has reduced debt.
  • Stock is trading at 0.40 times its book value

Weaknesses

7
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of -15.6% over past five years.
  • Promoter holding is low: 32.9%
  • Company has a low return on equity of -1.29% over last 3 years.
  • Company has high debtors of 532 days.
  • Promoter holding has decreased over last 3 years: -27.9%
  • Working capital days have increased from 260 days to 461 days

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1270
OscillatorsBearish270
Moving AveragesStrong Bearish1000

Key readings

RSI (14)
42.10
Neutral
MACD (12,26,9)
−0.13
Bearish
SMA (50)
7.15
Bearish
SMA (200)
11.06
Bearish

As of

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
5Y−15.59%
3Y−5.97%
1Y−5.84%

Net profit

Net profit growth by window
5Y−43.15%
3YTurned to profit
1Y−85.71%

Operating cash flow

Operating cash flow growth by window
5YTurned negative
3YTurned negative
1YTurned negative

Operating margin· change in pp

Operating margin growth by window
5Y−6.43 pp
3Y+14.68 pp
1Y−4.43 pp

Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2018₹2.79 Cr
Mar 2019₹5.26 Cr
Mar 2020₹6.10 Cr
Mar 2021₹9.78 Cr
Mar 2022₹11.28 Cr
Mar 2023₹5.04 Cr
Mar 2024₹4.81 Cr
Mar 2025₹4.45 Cr
Mar 2026₹4.19 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2018₹0.26 Cr
Mar 2019₹0.53 Cr
Mar 2020₹0.47 Cr
Mar 2021₹1.01 Cr
Mar 2022₹0.93 Cr
Mar 2023−₹1.56 Cr
Mar 2024₹0.62 Cr
Mar 2025₹0.42 Cr
Mar 2026₹0.06 Cr

Half-yearly Results

₹ Cr
541299 half-yearly results, ₹ crore
Particulars Mar 2020Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
3.07
2.71
7.07
8.02
3.26
2.28
2.76
2.73
2.08
2.13
2.33
2.05
2.13
Expenses
2.53
2.14
5.4
6.07
2.81
2.46
2.5
2.38
1.04
1.59
1.82
1.79
2
Operating Profit
0.54
0.57
1.67
1.95
0.45
−0.18
0.26
0.35
1.04
0.54
0.51
0.26
0.13
OPM %
17.59%
21.03%
23.62%
24.31%
13.8%
−7.89%
9.42%
12.82%
50%
25.35%
21.89%
12.68%
6.1%
Other Income
0
0
0
0
0
0.01
0
0
0.24
0
0
0.29
0
Interest
0.09
0.05
0.3
0.24
0.33
0.48
0.51
0.11
0.28
0.05
0.03
0.01
0.01
Depreciation
0.22
0.23
0.29
0.28
0.3
0.33
0.34
0.33
0.29
0.28
0.28
0.28
0.29
PBT
0.23
0.29
1.08
1.43
−0.18
−0.98
−0.59
−0.09
0.71
0.21
0.2
0.26
−0.17
Tax %
82.61%
24.14%
27.78%
25.17%
−22.22%
0%
0%
0%
0%
23.81%
−35%
26.92%
−17.65%
Net Profit
0.04
0.23
0.79
1.07
−0.13
−0.97
−0.59
−0.09
0.71
0.15
0.27
0.2
−0.13
EPS (₹)
0.05
0.26
0.91
1.23
−0.15
−1.11
−0.68
−0.1
0.82
0.17
0.31
0.23
−0.15

Profit & Loss

₹ Cr
541299 profit and loss, annual, ₹ crore
Particulars Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
2.79
5.26
6.1
9.78
11.28
5.04
4.81
4.45
4.19
Expenses
2.17
4.06
4.84
7.54
8.81
4.95
4.59
3.52
3.5
Operating Profit
0.62
1.2
1.26
2.24
2.47
0.09
0.22
0.93
0.69
OPM %
22.22%
22.81%
20.66%
22.9%
21.9%
1.79%
4.57%
20.9%
16.47%
Other Income
0.03
0.01
0
0
0
0
1.4
0.13
0
Interest
0.16
0.14
0.18
0.35
0.6
0.99
0.38
0.09
0.02
Depreciation
0.13
0.35
0.42
0.52
0.59
0.66
0.62
0.56
0.57
PBT
0.36
0.72
0.66
1.37
1.28
−1.56
0.62
0.41
0.1
Tax %
25%
26.39%
28.79%
26.28%
28.12%
0%
0%
−2.44%
30%
Net Profit
0.26
0.53
0.47
1.01
0.93
−1.56
0.62
0.42
0.06
EPS (₹)
0.44
0.61
0.54
1.16
1.07
−1.79
0.71
0.48
0.07
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%

Balance Sheet

₹ Cr
541299 balance sheet, annual, ₹ crore
Particulars Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
2.93
4.33
4.33
4.33
4.33
4.33
4.33
4.33
8.64
Reserves
0.4
3.73
4.21
5.22
6.15
4.59
5.21
5.62
5.5
Borrowings
1.88
0.9
1.76
4.04
5.15
6.4
3.48
4.07
2.06
Other Liabilities
1
1.18
1.63
1.61
2.49
2.4
1.97
1.72
1.4
Total Liabilities
6.21
10.14
11.93
15.2
18.12
17.72
14.99
15.74
17.6
Fixed Assets
2.06
3.28
3.47
5.24
5.75
5.39
3.99
3.51
3.27
CWIP
0
0
0
0
0
0
0
0
0
Investments
0.24
0.24
0.24
0.24
0.24
0.24
0.41
0.27
0.27
Other Assets
3.91
6.62
8.22
9.72
12.13
12.09
10.59
11.96
14.06
Total Assets
6.21
10.14
11.93
15.2
18.12
17.72
14.99
15.74
17.6

Cash Flow

₹ Cr
541299 cash flow, annual, ₹ crore
Particulars Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.58
−0.45
−0.1
1.19
2.01
0
−0.22
0.37
−0.76
Investing
−1.29
−1.95
−0.53
−2.26
−1.53
−0.2
1
0.06
−0.51
Financing
1.57
3.51
0.85
1.71
0.16
−0.23
−1.59
0.58
2.12
Net Cash Flow
0.85
1.12
0.23
0.64
0.64
−0.43
−0.81
1.01
0.84
Free Cash Flow
−0.73
−2.39
−0.71
−1.1
0.91
−0.3
0.74
0.3
−1.09
CFO/OP
94
−32
5
67
95
0
−100
40
−110

Ratios

541299 financial ratios, annual
Particulars Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
149
127
199
149
137
360
357
431
532
Inventory Days
167
233
159
68.75
191
459
255
490
307
Days Payable
427
407
355
97.06
175
404
218
365
110
Cash Conversion Cycle
−111
−46.54
2.47
120
152
414
394
557
729
Working Capital Days
162
167
206
105
77.98
188
164
157
461
ROCE %
—
12.14%
8.72%
14.4%
12.87%
−3.68%
−2.68%
2.81%
0.79%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Dr Lalchandani Labs insights

57 extracted metrics across FY18–FY26.

Shareholding Pattern

As of Mar 2026

  • Public 62.74%
  • Promoters 32.90%
  • Others 4.35%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Dr Lalchandani Labs

What does Dr Lalchandani Labs Ltd do?
Incorporated in 2011, Dr. Lalchandani Labs Ltd is in the business of running laboratories for pathological investigations
Where is Dr Lalchandani Labs Ltd (DLCL) listed?
Dr Lalchandani Labs Ltd trades under code 541299 on the BSE.
Which sector does Dr Lalchandani Labs Ltd belong to?
Dr Lalchandani Labs Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the 52-week high and low of Dr Lalchandani Labs Ltd?
Over the last 52 weeks Dr Lalchandani Labs Ltd has traded between ₹5.81 and ₹17.99 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Dr Lalchandani Labs Ltd?
Dr Lalchandani Labs Ltd reported a return on equity of 0.50%. Its debt-to-equity ratio is 0.15.

Company Information

Incorporated in 2011, Dr. Lalchandani Labs Ltd is in the business of running laboratories for pathological investigations

Website lalchandanipathlab.com
Listed 9 May 2018
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/541299.md for Dr Lalchandani Labs Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month